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a receptor for ALR, that may be important 
for signal transduction  [11] . Furthermore, 
ALR stimulates the mitogen-activated 
protein kinase cascade  [12] , decreases cy-
tochrome P450, increases nuclear factor-
  B activity  [13] , induces mRNA levels of 
pivotal enzymes of polyamine biosynthe-
sis and enhances polyamine levels in hu-
man hepatocytes  [14] .
 Although the beneficial effects of ALR 
in liver regeneration are well defined, a 
protective effect of ALR to reduce liver in-
jury is less clear. Cholestasis is a common 
cause of liver disease and is characterized 
by an elevation of hepatic levels of hydro-
phobic bile acids  [15–17] . Hepatocellular 
apoptosis induced by toxic, hydrophobic 
bile acids such as glycochenodeoxycholic 
acid (GCDCA) is a major cause of liver in-
jury in cholestasis  [18–20] .
 In view of ALR’s beneficial effects on 
liver regeneration, we analyzed the role of 
ALR to reduce liver injury induced by 
GCDCA in an in vitro model. For this pur-
pose, rat Na + -taurocholate cotransporting 
polypeptide (Ntcp) was stably transfected 
into the human hepatoma cell line HuH-
7 with a pcDNA3.1 vector using the
 Dear Sir, 
 In contrast to other organs, the liver is 
characterized by an outstanding capacity 
to regenerate after injuries of diverse eti-
ology. In this context, the protein aug-
menter of liver regeneration (ALR) is con-
sidered to be one of the major players in 
the process of hepatic regeneration  [1] 
and was found to support liver regenera-
tion in partially hepatectomized rats, in 
dogs with Eck fistula (portocaval shunt) 
 [2] , in rats with thioacetamide-induced 
liver injury  [3] , and to decrease hepatic fi-
brosis in carbon tetrachloride/ethanol-
injured rats  [4] . Moreover, after partial 
hepatectomy, an increase of serum but 
not of liver ALR levels was observed in 
rats  [5] , and increased expression of ALR 
mRNA was observed in cirrhotic human 
livers  [6] . ALR is a homolog of the Erv1 
protein from yeast that is essential for mi-
tochondrial respiration and cell viability 
 [7] , and is a member of the Erv1/ALR pro-
tein family of sulfhydryl oxidases  [8–10] . 
This protein family is important for mito-
chondrial biogenesis, cell cycle, and he-
patic and testicular organogenesis  [10] . 
Previous studies in rat hepatocytes and 
human HepG2 hepatoma cells described 
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FuGene  transfection reagent (Roche, 
Mannheim, Germany), similar as de-
scribed previously  [21] . These Ntcp-trans-
fected HuH-7 cells were then transiently 
transfected with a pcDNA3.1/Myc-HisB 
ALR construct  [22] using TransIT-LT1 re-
agent (Mirus Bio LLC, Madison, Wisc., 
USA) for 24 h. This had no effect on cel-
lular bile acid uptake as determined by liq-
uid scintillation counting of Ntcp-HuH-7 
cells after incubation with [ 3 H]taurocho-
late (data not shown).
 As expected, incubation of Ntcp-
HuH-7 cells with a low micromolar con-
centration of the hydrophobic bile acid 
GCDCA (20   mol/l) for 4 h led to a 7-fold 
increase (p  ! 0.01) of apoptotic cell death 
as determined by activities of caspases 3 
and 7 with the Apo-ONE homogeneous 
caspase-3/7 assay (Promega, Madison, 
Wisc., USA). Despite successful transfec-
tion of Ntcp-HuH-7 cells with the hepato-
poietic factor ALR as demonstrated by im-
munoblotting against the Myc-tag (with a 
monoclonal mouse anti-Myc antibody 
from Invitrogen, Carlsbad, Calif., USA) 
and by PCR amplification of ALR mRNA 
(2,635-fold higher mRNA level after ALR 
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transfection in comparison with controls), 
apoptotic cell death was not reduced under 
this condition ( fig. 1 ). In accordance with 
this observation, cell viability as deter-
mined by formazan formation with the 
WST-1 assay (Roche) and by quantifica-
tion of LDH activity  [23] in the culture me-
dium was not affected by ALR transfection 
either (data not shown).
 Taken together, overexpression of ALR 
had no beneficial effect on apoptosis in-
duced by low micromolar concentrations 
of GCDCA, which is one of the predomi-
nant bile acids found in cholestatic pa-
tients. Thus, our results suggest that ALR 
might not be beneficial in reducing hepa-
tocellular apoptosis in human cholestatic 
liver disease.
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 Fig. 1.  a A pcDNA3.1/Myc-HisB plasmid containing human ALR 
was successfully transfected into human hepatoma Ntcp-HuH-7 
cells as demonstrated by immunoblotting using an antibody 
against the Myc-tag of the plasmid and by amplification of ALR 
mRNA by PCR.  b Transfection of ALR does not ameliorate
GCDCA-induced apoptosis in Ntcp-HuH-7 cells that were incu-
bated with or without the hydrophobic bile acid GCDCA (20 
  mol/l). Apoptosis was quantified by determination of the ac-
tivities of the caspases 3 and 7. Results are expressed as % of con-
trol and means  8 SD of each 7 independent experiments.  * *  p  ! 
0.01 vs. control (no GCDCA);  ##  p  ! 0.01 vs. ALR (no GCDCA) 
(ANOVA with Tukey’s post-hoc test). 
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